Anemia of cancer

Hematology/Oncology Clinics of North America

Volumn 10, Issue 2, 1996, Pages 345-362

  Moliterno, A R ^a   Spivak, J L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BURST FORMING UNIT E; CANCER; CANCER HORMONE THERAPY; CLINICAL TRIAL; COLONY FORMING UNIT E; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG INDICATION; ERYTHROID PRECURSOR CELL; HUMAN; IRON METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029869929     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70342-7     Document Type: Article

References (78)

1. R.I. Abels K.M. Larholt K.D. Krantz Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer M.J. Murphy Jr Blood Cell Growth Factors: Their Present and Future Use in Hematology and Oncology 1991 Alpha Med Press Dayton, OH 121
2. K.H. Antman A.T. Skarin R.J. Mayer Microangiopathic hemolytic anemia and cancer. A review Medicine 58 1979 377
3. X. Alvarez-Hernandez J. Liceaga I.C. McKay Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor Lab Invest 61 1989 319
4. B. Barlogie T. Beck Recombinant human erythropoietin and the anemia of multiple myeloma Stem Cells 11 1993 88
5. W.E. Berdel D. Oberberg B. Reufi Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro Ann Hematol 63 1991 5
6. V.C. Broudy N. Lin M. Brice Erythropoietin receptor characteristics in primary human erythroid cells Blood 77 1991 2583
7. O.R. Busch W.C. Hop M.A. Hoynck van Papendrecht Blood transfusions and prognosis in colorectal cancer N Engl J Med 328 1993 1372
8. R.S. Bush The significance of anemia in clinical radiation therapy Int J Radiat Biol Phys 12 1986 2047
9. J.E. Cantrell T.M. Phillips P.S. Schein Carcinoma-associated hemolytic-uremic syndrome: A complication of mitomycin C chemotherapy J Clin Oncol 3 1985 723
10. I. Cavill C. Ricketts J.A.F. Napier Erythropoiesis in the anaemia of chronic disease Scand J Haematol 19 1977 509
11. S. Cascinu A. Fedeli E. Del Ferro Recombinant human erythropoietin treatment in cisplatin-associated anemia: A randomized, double-blind trial with placebo J Clin Oncol 12 1994 1058
12. M. Cazzola L. Ponchio Y. Beguin Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial Blood 79 1992 29
13. M. Chandra G.K. Clemons M.I. McVicar Relation of serum erythropoietin levels to renal excretory function: Evidence for lowered set point for erythropoietin production in chronic renal failure J Pediatr 113 1988 1015
14. R. Cox T. Musial O.H.B. Gyde Reduced erythropoietin levels as a cause of anemia in patients with lung cancer Eur J Cancer Clin Oncol 22 1986 511
15. N. Dainiak V. Kulkarni D. Howard Mechanisms of abnormal erythropoiesis in malignancy Cancer 51 1983 1101
16. E.S. deCampos J.R. Radford W.P. Steward The effect of rHu erythropoietin (EPO) on levels of hemoglobin and number of red cell and platelet transfusion during intensive chemotherapy for small cell lung carcinoma [abstract] Br J Cancer 63 Suppl 13 1991 9
17. R.L. DeGowin D.P. Gibson Erythropoietin and the anemia of mice bearing extramedullary tumor J Clin Med 94 1979 303
18. T.A. Denton G.A. Diamond J.M. Matloff Anemia therapy: Individual benefit and societal cost Semin Oncol 21 Suppl 3 1994 29
19. D.C. Doll R.B. Weiss Hemolytic anemia associated with antineoplastic agents Cancer Treat Rep 69 1985 777
20. J.P. Doweiko M.A. Goldberg Erythropoietin therapy in cancer patients Oncology 5 1991 31
21. K. Dusenberry W. McGuire L. Carson Recombinant human erythropoietin (rHuEPO) increases hemoglobin during radiation therapy for cervix cancer Proc Am Soc Clin Oncol 12 1993 828a
22. J.C. Egrie P.M. Cotes J. Lane Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen J Immunol Methods 99 1987 235
23. W.C. Faquin T.J. Schneider M.A. Goldberg Effect of inflammatory cytokines on hypoxiainduced erythropoietin production Blood 79 1992 1987
24. T. Gamucci M.F. Thorel A.M. Frasca Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin Eur J Cancer 29A Suppl 2 1993 S13
25. E.P. Getaz S. Beckley J. Fitzpatrick Cisplatin-induced hemolysis N Engl J Med 302 1980 334
26. D.H. Henry Clinical application of recombinant erythropoietin in anemic cancer patients Hematol Oncol Clin North Am 8 1994 961
27. D.H. Henry R.I. Abels Recombinant human erythropoietin in the treatment of chemo-therapy-induced anemia: Results of long-term, open label, follow-up studies Semin Oncol 21 1994 21
28. D. Henry R. Nelson B. Brooks Prospective evaluation of transfusion requirement for anemic cancer patients +/- chemotherapy [abstract] Proc Annu Meet Am Soc Clin Oncol 10 1991 A1203
29. D.H. Henry A.P. Staddon B.A. Mason Prevention of anemia in breast cancer patients receiving Adriamycin-containing chemotherapy with recombinant human erythropoietin [abstract] Blood 78 Suppl 1 1991 10
30. P.J. Hesketh T.P. Cooley H.E. Finkel Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C Cancer 62 1988 1466
31. D.G. Hirst Anemia: A problem or an opportunity in radiotherapy? Int J Radiat Oncol Biol Phys 12 1986 2009
32. M.C. Hochberg C.M. Arnold B.B. Hogans Serum immunoreactive erythropoietin in rheumatoid arthritis: Impaired response to anemia Arthritis Rheum 31 1988 1318
33. A.M. Jackson B.D. Rose L.G. Graff Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy Ann Intern Med 101 1984 41
34. R.D. James P.M. Wilkinson F. Belli Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: Preliminary results Acta Haematol 87 Suppl 1 1992 12
35. W. Jelkmann H. Pagel M. Wolff Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys Life Sci 50 1991 301
36. C.S. Johnson C.A. Cook P. Furmanski In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): Reversal with exogenous erythropoietin (EPO) Exp Hematol 18 1990 109
37. C.S. Johnson D.J. Keckler M.I. Topper In vivo hemopoietic effects of recombinant IL-1 in mice. Stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin Blood 73 1989 678
38. S.E. Jones Autoimmune disorders and malignant lymphoma Cancer 31 1973 1092
39. H. Klein Transfusion in transplant patients: The good, the bad, and the ugly J Heart Lung Transplant 12 1 1993 S7
40. M.J. Koury M.C. Bondurant Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells Science 248 1990 378
41. S.T. Koury M.C. Bondurant M.J. Koury Localization of cells producing erythropoietin in murine liver by in situ hybridization Blood 77 1991 2497
42. S.T. Koury M.J. Koury M.C. Bondurant Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: Correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration Blood 74 1989 645
43. M.E. Kuzur F.A. Greco Cisplatin-induced anemia [letter] N Engl J Med 303 1980 110
44. K.T. Landschultz A.N. Noyes O. Rogers Erythropoietin receptors on murine erythroid colony forming cells: Natural history Blood 73 1989 1476
45. R.S. Lavey W.H. Dempsey Erythropoietin increases hemoglobin in cancer patients during radiation therapy Int J Radiat Oncol Biol Phys 27 1993 1147
46. C. Leitgeb M. Pecherstorfer E. Fritz Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin Cancer 73 1994 2535
47. H.P. Lohrmann W. Adam B. Heymer Microangiopathic hemolytic anemia in metastatic carcinoma: Report of eight cases Ann Intern Med 79 1973 368
48. H. Ludwig E. Fritz H. Kotzmann Erythropoietin treatment of anemia associated with multiple myeloma N Engl J Med 322 1990 1693
49. H. Ludwig E. Fritz C. Leitgeb Prediction of response to erythropoietin treatment in chronic anemia of cancer Blood 84 1994 1056
50. R.T. Means E.N. Dessypris S.B. Krantz Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon J Cell Physiol 150 1992 59
51. R.T. Means S.B. Krantz Inhibition of human erythroid colony-forming units by interferon can be corrected by recombinant human erythropoietin Blood 78 1991 2564
52. R.T. Means S.B. Krantz Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon J Clin Invest 91 1993 416
53. C.B. Miller R.J. Jones S. Piantadosi Decreased erythropoietin response in patients with the anemia of cancer N Engl J Med 322 1990 1689
54. C.B. Miller L.C. Platanias S.R. Mills Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia J Natl Cancer Inst 84 1992 98
55. O. Miura N. Nakamura F.W. Quelle Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo Blood 84 1994 1501
56. K. Muta S. Krantz Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor-1 as well as erythropoietin J Cell Physiol 156 1993 264
57. T. Nakahata A.J. Gross M. Ogawa A stochastic model of self-renewal and commitment to differentiation of the primitive hemopoietic stem cells in culture J Cell Physiol 113 1982 455
58. P.M. Ness P.C. Walsh M. Zahurak Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood Transfusion 32 1992 31
59. W. Oster F. Hermann H. Gamm Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration J Clin Oncol 80 1990 956
60. J. Overgaard H.S. Hansen K. Jorgensen Primary radiotherapy of larynx and pharynx carcinoma—an analysis of some factors influencing local control and survival Int J Radiat Oncol Biol Phys 12 1986 515
61. W.R. Reed D.H. Hussey R.L. DeGowin Implications of the anemia of chronic disorders in patients anticipating radiotherapy Am J Med Sci 308 1994 9
62. A.H. Rossof R.E. Slayton C.P. Perlia Preliminary clinical experience with cis-diamminedichloroplatinum (II) Cancer 30 1972 1451
63. S.A. Rothmann P. Paul J.K. Weick Effect of cis-diamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells International Journal of Cell Cloning 3 1985 415
64. W. Schreml H.P. Lohrmann B. Anger Stem cell defects after cytoreductive therapy in man Exp Hematol 13 Suppl 16 1985 31
65. R. Sheldon D. Slaughter A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma Cancer 58 1986 1428
66. F.A. Shepherd W.K. Evans R. MacCormick Cyclophosphamide, doxorubicin, and vincristine in etoposide-and cisplatin-resistant small cell lung cancer Cancer Treat Rep 71 1987 941
67. J.R. Skillings F.G. Sridhar C. Wong The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study Am J Clin Oncol 16 1993 22
68. D.H. Smith C.M. Guarnieri S.M. Whaling Erythropoietin response in cancer patients receiving cisplatin [abstract] Proc Am Assoc Cancer Res 29 1988 52
69. M.A. Spira E.C. Lynch Autoimmune hemolytic anemia and carcinoma: An unusual association Am J Med 67 1979 753
70. J.L. Spivak D.C. Barnes E. Fuchs Serum immunoreactive erythropoietin in HIV-infected patients JAMA 261 1989 3104
71. J.L. Spivak B.B. Hogans Clinical evaluation of a radioimmunoassay for serum erythropoietin using reagents derived from recombinant erythropoietin [abstract] Blood 70 Suppl 1 1987 143
72. J.L. Spivak T. Pham M. Isaacs Erythropoietin is both a mitogen and a survival factor Blood 77 1991 1228
73. S. Vijayakumar M. Roach W. Wara Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, phase II trial Int J Radiat Oncol Biol Phys 26 1993 721
74. D.D. Von Hoff R. Schilsky C.M. Reichert Toxic effects of cis-dichlorodiammineplatinum (II) in man Cancer Treat Rep 63 1979 1527
75. P.A. Wood W.J. Hrushesky Cisplatin-associated anemia: An erythropoietin deficiency syndrome J Clin Invest 95 1995 1650
76. H.S. Wu A.G. Little Perioperative blood transfusions and cancer recurrence J Clin Oncol 6 1988 1348
77. H. Youssoufian G. Longmore D. Neumann Structure, function, and activation of the erythropoietin receptor Blood 81 1993 2223
78. S. Zucker R.M. Lysik J.F. DiStefano Cancer cell inhibition of erythropoiesis J Lab Clin Med 96 1980 770